Home/CKP Therapeutics/Ki Cheong Park
KC

Ki Cheong Park

Chief Scientific Officer

CKP Therapeutics

Therapeutic Areas

CKP Therapeutics Pipeline

DrugIndicationPhase
C7Drug-Resistant Papillary Thyroid CarcinomaPre-clinical
C13Drug-Resistant Papillary Thyroid CarcinomaPre-clinical
C19Drug-Resistant Hepatocellular CarcinomaPre-clinical
C23Drug-Resistant Hepatocellular CarcinomaPre-clinical